Jupiter Life Line Hospitals (JLHL.NS) Stock Price

Jupiter Life Line Hospitals Price

BSE·CLOSED
247.05
​
Market closed

Over the last 6 years Jupiter Life Line Hospitals grew revenue by 21.6% annually, reaching 15.00 B INR. Earnings per share have grown at 36.8% per year over the last 6 years. For Jupiter Life Line Hospitals, the net margin of 12.9% is up versus 7.0% a few years ago. At today's price the dividend yield works out to roughly 0.08%. The payout ratio is around 4% of earnings.

Jupiter Life Line Hospitals stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jupiter Life Line Hospitals business model & stock analysis

Jupiter Life Line Hospitals Ltd, headquartered in Thane, Maharashtra, operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. The company provides healthcare services with a total bed capacity of approximately 1,194 across its facilities, supported by over 1,246 doctors, including specialists and surgeons. It is focused on developing a multi-specialty hospital in Dombivli, Maharashtra, and has subsidiaries such as Jupiter Hospitals Projects Private Limited and Medulla Healthcare Private Limited. Listed on 18 September 2023, the company operates within the Health Care sector.

Frequently asked questions about Jupiter Life Line Hospitals

11 analysts currently rate the Jupiter Life Line Hospitals stock: 10 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Jupiter Life Line Hospitals share trades at 2.31 EUR (247.05 INR).

The revenue of Jupiter Life Line Hospitals is 15.00 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Jupiter Life Line Hospitals is 1.94 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Jupiter Life Line Hospitals is currently 41.71. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Jupiter Life Line Hospitals stock.

The price-to-sales ratio (P/S) of Jupiter Life Line Hospitals is currently 5.40. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Jupiter Life Line Hospitals stock.

The Eulerpool Quality Score for Jupiter Life Line Hospitals is 5/10.

The ISIN of Jupiter Life Line Hospitals is INE682M01012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Jupiter Life Line Hospitals is JLHL.NS. The ticker symbol is used to trade Jupiter Life Line Hospitals shares on the stock exchange.

Fair ValueTerminal
237.17 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Sep 18, 2023
ISIN
INE682M01012
Cusip
Y4S77P107
Market capitalization
16.20 B INRLarge Cap
52-Week Range
PEG
2.23
P/E ratio
P/Ee 2027
39.32
P/Ee 2028
30.95
P/Ee 2029
23.53
P/S
P/Se
4.51
EV/EBIT
7.44
P/B Ratio
1.05
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.12 %
Dividend
Dividend yield
0.08 %
Est. Dividend Yield
0.08 %
Payout Ratio
3.55 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
2 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 18, 2026, 4:34 AM

Jupiter Life Line Hospitals Peer Group

Jupiter Life Line Hospitals Ticker

BSE · JLHL.BO

Jupiter Life Line Hospitals FIGI

JLHL:IN · BBG002YV64S4JLHL:IB · BBG01J67QFN8JLHL:IS · BBG01J67QFQ5